Present status and future perspectives on the development of bioartificial kidneys for the treatment of acute and chronic renal failure patients

Hemodialysis International

Volumn 15, Issue 2, 2011, Pages 183-192

  Saito, Akira ^a   Sawada, Kaichiro ^a   Fujimura, Satoshi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute kidney injury; Artificial glomerulus; Bioartificial glomerulus; Bioartificial kidney; Bioartificial tubule device; Continuous hemofiltration; Semipermeable membrane; Tubular epithelial cells

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 METHACRYLOYLOXYETHYLPHOSPHORYLCHOLINE; CD133 ANTIGEN; POLYMER; POLYSULFONE;

ACUTE KIDNEY FAILURE; ARTIFICIAL KIDNEY; BIOARTIFICIAL ORGAN; BIOCOMPATIBILITY; CHRONIC KIDNEY FAILURE; CONTINUOUS HEMOFILTRATION; DEVICE; HOLLOW FIBER; HUMAN; IMPLANTATION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; NONHUMAN; REVIEW; SURVIVAL RATE;

ACUTE KIDNEY INJURY; ANIMALS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY, ARTIFICIAL; RENAL DIALYSIS;

EID: 79954601355     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2011.00530.x     Document Type: Review

References (41)

1. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol. 1989; 257:L163-L173.
2. Asano M, Fujita Y, Ueda Y, et al. Renal proximal tubular metabolism of protein-linked pentosidine, an advanced glycation end product. Nephron. 2002; 91:688-694.
3. Maack T. Renal handling of proteins and polypeptides. In: Windhager EE, ed. Handbook of Physiology. New York: Oxford University Press; 1992:2039-2118.
4. Stadnyk AW. Cytokine production by epithelial cells. FASEB J. 1994; 8:1041-1047.
5. Aebischer P, Ip TK, Miracoli L, Galletti PM. Renal epithelial cells grown on semipermeable processor. Trans Am Soc Artif Intern Organs. 1987; 33:96-102.
6. Aebischer P, Ip TK, Galletti PM. The bioartificial kidney: Progress toward an ultrafiltration device with renal epithelial cells processing. Life Support Sys. 1987; 5:159-168.
7. Ip TK, Aebischer P. Renal epithelial cell-controlled solute transport across permeable membrane as the foundation for bioartificial kidney. Artif Organs. 1987; 13:58-61.
8. Humes HD, MacKay SM, Funke AJ, Buffington DA. Tissue engineering of a bioartificial renal tubule assist device: In vitro transport and metabolic characteristics. Kidney Int. 1999; 55:2502-2514.
9. Saito A, Suzuki H, Bomsztyk K, Ahmad S. Regeneration of peritoneal effluent by Madin-Darby canine kidney cells-lined hollow fibers. Mater Sci & Eng C. 1998; 6:221-226.
10. Kanai N, Fujita Y, Kakuta T, Saito A. Effect of extracellular matrix on renal epithelial cell attachment on the polymer substrate. Artif Organs. 1999; 23:114-118.
11. Fujita Y, Kakuta T, Asano M, Saito A. Evaluation of active transport and morphological changes for bioartificial renal tubule device using MDCK cells. Tissue Eng. 2002; 8:13-24.
12. 1 cells on porous polymer membranes for the development of a bioartificial renal tubule device. Tissue Eng. 2005; 11:1506-1515.
13. Terashima M, Fujita Y, Sugano K, et al. Evaluation of water and electrolyte transport of tubular epithelial cells under osmotic and hydraulic pressure for development of bioartificial tubules. Artif Organs. 2001; 25:209-212.
14. Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol. 1999; 17:451-455.
15. 1. Nephrol Dial Transplant. 2004; 19:2198-2207.
16. Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol. 2003; 14:454-461.
17. 1 cells in the development of a portable bioartificial renal tubule device. Tissue Eng. 2004; 10:711-722.
18. Tsuruoka S, Sugimoto KI, Ueda K, Imai M. Removal of digoxin and doxorubicin by multidrug resistant protein-overexpressed cell culture in hollow fiber. Kidney Int. 1999; 56:154-163.
19. Tsuruoka S, Nishiki K, Sugimoto K, Suzuki M, Imai M, Fujimura A. Specific therapy of digoxin intoxication in dogs by hybrid kidney overexpressing multidrug resistance protein. Kidney Int. 2002; 62:1332-1337.
20. Saito A. Research in the development of a wearable bioartificial kidney with a continuous hemofilter and a bioartificial tubule device using tubular epithelial cells. Artif Organs. 2004; 28:8-63.
21. Humes HD, Weitzel WF, Bartlett RH, et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 2004; 66:1578-1588.
22. Tumlin J, Wali R, Williams W, et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Sc Nephrol. 2008; 19:1034-1040.
23. Inagaki M, Yokoyama TA, Sawada K, et al. Prevention of LLC-PK1 cell overgrowth in a bioartificial renal tubule device using a MEK inhibitor, U0126. J Biotechnol. 2007; 132:57-64.
24. Saito A, Aung T, Sekiguchi K, et al. Present status and perspective of bioartificial kidneys. J Artif Organs. 2006; 9:130-135.
25. Tatsumi E, Takano H, Taenaka Y. Development of a novel integrated heart-lung assist device-A heparin-coated, preprimed, all-in-one system. ASAIO. 1998; 20A.
26. Tatsumi E, Takano H, Taenaka Y. Development of an ultracompact integrated heart-lung assist device. Artif Organs. 1999; 23:518-523.
27. Ishihara K, Tsuji T, Kurosaki T, Nakabayashi N. Hemocompatibility on graft copolymers composed of poly(2-methacryloyloxyethyl phosphorylcholine) side chain and poly(n-butyl methacrylate) backbone. J Biomed Mater Res. 1992; 28:225-232.
28. Ishihara K, Fukumoto K, Miyazaki H, Nakabayashi N. Improvement of blood compatibility on cellulose dialysis membrane with a novel biomedical polymer having a phospholipid polar group. Artif Organs. 1994; 18:559-564.
29. Vu DM, Yokoyama TA, Sawada K, et al. Enhancement of permeability in endothelial cells for the development of an antithrombogenic bioartificial henofilter. Biotech Bioeng. 2008; 101:634-641.
30. + endothelial progenitor cells as a potential cell source for a bioartificial glomerulus. Tissue Eng A. 2009; 15:3173-3182.
31. Hasegawa T, Iwasaki Y, Ishihara K. Preparation of blood compatible hollow fibers from a polymer alloy composed of polysulfone and 2-methacryloyloxyethyl phosphorylcholine polymer. J Biomed Mater Res Appl Biomat. 2002; 63:333-341.
32. Ueda H, Watanabe J, Konno T, Takai M, Saito A, Ishihara K. Asymmetrically functional surface properties on biocompatible phospholipid polymer membrane for bioartificial kidney. J Biomed Mater Res. 2006; 77A:19-27.
33. Gura V, Macy AS, Beizai M, Ezon C, Golper TA. Technical breakthroughs in the wearable artificial kidney (WAK). Clin J Am Soc Nephrol. 2009; 4:1441-1448.
34. Fissel WH, Roy S. The implantable artificial kidney. Semin Dial. 2009; 22:665-670.
35. Nissenson AR, Ronco C, Pergamit G, Edelstein M, Watts R. The human nephron filter: Toward a continuously functioning, implantable artificial nephron system. Blood Purif. 2005; 23:269-274.
36. Tiranathanagul K, Dhwan V, Lytle IF, et al. Tissue engineering of an implantable bioartificial hemofilter. ASAIO J. 2007; 53:176-186.
37. Fissell HW, Fleischman AJ, Humes HD, Roy S. Development of continuous implantable renal replacement: Past and future. Transl Res. 2007; 150:327-336.
38. Dörp E, Wüstenberg PW, Schumann L, et al. Hemorheological/hemodynamic study on miniaturized capillary filters in the concept of an implantable artificial kidney. Z Exp Transplant Kunstiche Organe. 1988; 21:119-127.
39. Adiga SP, Curtiss LA, Monteiro-Riviere NA, Narayan RJ. Nanoporous membranes for medical and biological applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009; 1:568-581.
40. Narayan RJ, Aggarwal R, Wei W, et al. Mechanical and biological properties of nanoporous carbon membranes. Biomed Mater. 2008; 3:034107.
41. Handley HH, Gorsuch R, Levin W, Ronco C. Intravenous catheter for intracorporeal plasma filtration. Blood Purif. 2002; 20:61-69.